Stay Tuned to the LDL Controversy

Debate continues about when to monitor and how to manage LDL.

We know the new thinking is to use target DOSES of statins to reduce CV risk...instead of titrating to a specific LDL goal.

But don't use a "fire and forget" approach.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote